{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:19:31Z","timestamp":1781594371062,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1124\/dmd.113.055228","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T23:21:43Z","timestamp":1390605703000},"page":"537-540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["The Effect of ABCG2 and ABCC4 on the Pharmacokinetics of Methotrexate in the Brain"],"prefix":"10.1016","volume":"42","author":[{"given":"Ramola","family":"Sane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Pei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.113.055228_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/jpet.110.167601","article-title":"Distribution of gefitinib to the brain is limited by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)-mediated active efflux","volume":"334","author":"Agarwal","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.055228_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/jpet.110.175034","article-title":"The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brain","volume":"336","author":"Agarwal","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.055228_bib3","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1124\/dmd.112.044719","article-title":"Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp\/Bcrp knockout mice","volume":"40","author":"Agarwal","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.055228_bib4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1158\/0008-5472.CAN-06-2680","article-title":"Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue-induced damage","volume":"67","author":"Belinsky","year":"2007","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.113.055228_bib5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11060-008-9678-2","article-title":"Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study","volume":"91","author":"Blakeley","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1124\/dmd.113.055228_bib6","first-page":"6359","article-title":"Dose-dependent pharmacokinetics of methotrexate and 7-hydroxymethotrexate in the rat in vivo","volume":"49","author":"Bremnes","year":"1989","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.113.055228_bib7","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1021\/mp900178j","article-title":"ABC and SLC transporter expression and pot substrate characterization across the human CMEC\/D3 blood-brain barrier cell line","volume":"7","author":"Carl","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.113.055228_bib8","first-page":"3144","article-title":"Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system","volume":"62","author":"Chen","year":"2002","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.113.055228_bib9","first-page":"4048","article-title":"Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(\u03b2-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport","volume":"63","author":"Chen","year":"2003","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.113.055228_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jneumeth.2008.12.010","article-title":"Quantitative microdialysis using modified ultraslow microdialysis: direct rapid and reliable determination of free brain concentrations with the MetaQuant technique","volume":"178","author":"Cremers","year":"2009","journal-title":"J Neurosci Methods"},{"key":"10.1124\/dmd.113.055228_bib11","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1200\/JCO.2003.08.900","article-title":"Primary central nervous system lymphoma: a curable brain tumor","volume":"21","author":"DeAngelis","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1124\/dmd.113.055228_bib12","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1158\/1078-0432.CCR-06-2854","article-title":"The blood-brain barrier and cancer: transporters, treatment, and Trojan horses","volume":"13","author":"Deeken","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.113.055228_bib13","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s002800050518","article-title":"In vivo microdialysis to characterize drug transport in brain tumors: analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats","volume":"38","author":"Devineni","year":"1996","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1124\/dmd.113.055228_bib14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1586\/14737140.7.5.689","article-title":"Primary CNS lymphoma","volume":"7","author":"Gerstner","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1124\/dmd.113.055228_bib15","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.jpba.2006.12.034","article-title":"Determination of methotrexate and its major metabolite 7-hydroxymethotrexate in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry","volume":"43","author":"Guo","year":"2007","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/dmd.113.055228_bib16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/1471-2407-10-257","article-title":"Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study","volume":"10","author":"Jacot","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1124\/dmd.113.055228_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1124\/jpet.108.140475","article-title":"Increasing systemic exposure of methotrexate by active efflux mediated by multidrug resistance-associated protein 3 (mrp3\/abcc3)","volume":"327","author":"Kitamura","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.055228_bib18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1124\/jpet.109.162321","article-title":"Kinetic analysis of the cooperation of P-glycoprotein (P-gp\/Abcb1) and breast cancer resistance protein (Bcrp\/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone","volume":"333","author":"Kodaira","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.055228_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-005-9044-6","article-title":"Systemic high-dose intravenous methotrexate for central nervous system metastases","volume":"78","author":"Lassman","year":"2006","journal-title":"J Neurooncol"},{"key":"10.1124\/dmd.113.055228_bib20","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1128\/MCB.24.17.7612-7621.2004","article-title":"Mrp4 confers resistance to topotecan and protects the brain from chemotherapy","volume":"24","author":"Leggas","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1124\/dmd.113.055228_bib21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1124\/dmd.112.049254","article-title":"Brain efflux index to investigate the influence of active efflux on brain distribution of pemetrexed and methotrexate","volume":"41","author":"Li","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.055228_bib22","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1158\/1078-0432.CCR-12-3105","article-title":"Abcc4 together with abcb1 and abcg2 form a robust cooperative drug efflux system that restricts the brain entry of camptothecin analogues","volume":"19","author":"Lin","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.113.055228_bib23","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1124\/dmd.109.026674","article-title":"Unbound brain concentration determines receptor occupancy: a correlation of drug concentration and brain serotonin and dopamine reuptake transporter occupancy for eighteen compounds in rats","volume":"37","author":"Liu","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.055228_bib24","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1227\/00006123-199105000-00023","article-title":"Continuous intratumoral infusion of methotrexate for recurrent glioblastoma: a pilot study","volume":"28","author":"Nierenberg","year":"1991","journal-title":"Neurosurgery"},{"key":"10.1124\/dmd.113.055228_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/dmd.108.024018","volume":"37","author":"Ose","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.055228_bib26","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1172\/JCI118699","article-title":"P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs","volume":"97","author":"Schinkel","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.113.055228_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011","journal-title":"J Neurochem"},{"key":"10.1124\/dmd.113.055228_bib28","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1681\/ASN.V133595","article-title":"The MRP4\/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP","volume":"13","author":"van Aubel","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/dmd.113.055228_bib29","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1158\/1535-7163.MCT-09-0668","article-title":"Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo","volume":"8","author":"Vlaming","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/dmd.113.055228_bib30","first-page":"5538","article-title":"Wild-type breast cancer resistance protein (BCRP\/ABCG2) is a methotrexate polyglutamate transporter","volume":"63","author":"Volk","year":"2003","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.113.055228_bib31","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1124\/dmd.111.041228","article-title":"Dose-dependent disposition of methotrexate in Abcc2 and Abcc3 gene knockout murine models","volume":"39","author":"Wang","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.055228_bib32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11060-010-0334-2","article-title":"High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D pilot study","volume":"102","author":"Wolff","year":"2011","journal-title":"J Neurooncol"},{"key":"10.1124\/dmd.113.055228_bib33","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1124\/mol.106.026955","article-title":"The important role of Bcrp (Abcg2) in the biliary excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in mice","volume":"70","author":"Zamek-Gliszczynski","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.113.055228_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1215\/15228517-2008-067","article-title":"High-dose methotrexate for elderly patients with primary CNS lymphoma","volume":"11","author":"Zhu","year":"2009","journal-title":"Neuro-oncol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624113918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624113918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.113.055228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T14:33:45Z","timestamp":1739889225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624113918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0090955624113918"],"URL":"https:\/\/doi.org\/10.1124\/dmd.113.055228","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718252776.793492003","asserted-by":"object"}]},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effect of ABCG2 and ABCC4 on the Pharmacokinetics of Methotrexate in the Brain","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.113.055228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}